ActivePure Technology has been proven effective against a broad spectrum of clinically relevant pathogens. Every pathogen has a different level of resistance which is outlined in the hierarchy of pathogens below. This hierarchy is used to help predict the ability of a device or chemical to reduce an emerging pathogen. The founding principle, with some exceptions, is that if you are able to demonstrate effectiveness on a higher-class pathogen at the top of the pyramid then there is a presumed level of efficacy against lower-class pathogens at the bottom.

You will see that ActivePure has proven 99.99%+ effectiveness against Bacillus Globigii spores. By achieving this, we are able to claim efficacy against lower-class pathogens at the bottom of the pyramid, like SARS-CoV-2 responsible for COVID-19. We also have test results against SARS-CoV-2.